Tandem HF Advantages



Tandem™ HF rapidly solves the therapeutic cell retention problem by binding cells, relieving anoikis and when delivered into the heart, anchoring cells in the damaged tissue. Furthermore, Tandem™ HF dampens down the immune system reducing cell loss due to immune rejection.


      • First of its kind injectable, human heart cell-derived biomatrix
      • Enables retention, distribution of therapeutic cells
      • Therapeutic cells readily bind and dissociate with biomatrix
      • Favorable biomatrix composition replenishes damaged heart muscle


Small-animal studies using relevant pre-clinical models have demonstrated that the properties of Tandem™ HF provide a unique advantage to the use of cell therapies alone.



Blue: Cells delivered without Tandem™ HF (<5% cell retention)

Yellow: Cells delivered with Tandem™ HF (>80% cell retention)